Share
Now
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Event Speakers
MUKESH KUMAR
Cipla
MUKESH KUMAR
Cipla
MUKESH KUMAR, Senior Vice President & Head, Clinical R&D, Cipla
• Internationally experienced industry physician (MD) and R&D leader with 20 years of experience in leading clinical development, clinical pharmacology, translational research, biopharmaceutics and preclinical functions in multinational pharma and academic organizations.
• Seasoned R&D professional, currently Head of Clinical R&D, responsible for clinical and preclinical development in a multinational pharma focussed on the development of complex generic and specialty products, including drug device combinations, in respiratory, pain, antimicrobial therapy area
• Formerly, Clinical Research Director and regional Head of Clinical/Clinical Pharmacology in global innovator pharma R&D responsible for global registration of NCEs/bio-better/ repurposed products in multiple therapeutic area- respiratory, oncology, infection, cardiovascular metabolic, dermatology and neurology
• Experienced member of committees responsible for Go/No-Go decision on phase transition and portfolio selection and chairman of Bio-council for Go/No-Go decision and scientific recommendation on developmental issues
• Successful collaboration experience and strong network with KOLs, AROs, CROs and solid understanding of global pharma R&D, organization, ecosystem and synergy potential
SUYAMBURAM S
Sun Pharma(UAE)
SHALIGRAM R
Lupin
SHALIGRAM R
Lupin
SHALIGRAM RANE, Vice President & Site Head Quality, Lupin
Result oriented career spanning over 28 years in various pharma industry and 2 years in academic
He believe on success through faster decisions by considering techno‐commercial risk factors.
SYNOPSIS:
He completed Ph.D. in Applied Chemistry from M.S. University, Baroda,
M. Sc. in Organic Chemistry from Poona University and
M. Ed. from Uttar Maharashtra Vidyapeeth, Jalgaon.
He proved his domain expertise in Quality and GMP department at various renowned
organizations like Intas, Dishman, Cadila, Glenmark, Sun, Aarti and with Govt. Polytechnic College.
Currently working with Lupin as Vice President and heading Quality department of Biotech
Division of Lupin Ltd., Pune.
He handled successfully more than 200 different types of regulatory inspection including FDA,
EMA, PMDA, ANVISA, TGA, MCC, GCC, etc.
Inspected more than 100 inspections at various overseas pharma industry / laboratory.
He delivered talk on GMP topics in various workshops and conferences.
RAHUL GUPTA
USV
RAHUL GUPTA
USV
RAHUL GUPTA, Vice President, Regulatory Affairs, USV
• Rahul Gupta is presently Senior Vice President – Regulatory Affairs at USV Pvt Ltd. Prior to USV, he has worked in Sun Pharma, Piramal enterprise and many other pharmaceutical companies.
• Rahul has over 25 years of experience in the various pharmaceutical area. He has regulatory experience for development of new molecules from discovery to Phase I to Phase III.
• He has worked on cancer, anti-analgesic, anti-infective, metabolic disorder drugs in area of new drug development- having experience of successfully filing about 60 Phase I / II and III IND / CT applications across various continent, which includes USA, Europe, Australia, Canada and India.
• He has also worked on more than 70 ANDA’s and generic European submission for various dosage form- solid orals, parenterals, nasal sprays and complex generics etc, also having experience of DMFs/CEPs/ASMFs in regulated countries.
• He is M.Sc in Pharmaceutical chemistry and MBA in Operational management. He was also an adjunct faculty at Mumbai University (Bombay college of pharmacy), NMIMS and many other academic institutes in India.
SAMIR KULKARNI
Institute of Chemical Technology
SAMIR KULKARNI
Institute of Chemical Technology
SAMIR KULKARNI, Head, Biological Sciences and Biotechnology, Institute of Chemical Technology
KETAKI S-P
Lupin
KETAKI S-P
Lupin
KETAKI SABNIS-PRASAD, Assistant Director & Head Development Quality Assurance Biotech, Lupin
Dr. Ketaki has more than 15 years of experience in Biotech industry in Development Quality Assurance and Process Development. She has technical expertise on complex biosimilars which include Monoclonal Antibodies, fusion proteins, antibody fragments and other therapeutic proteins.
Ketaki holds a bachelor’s degree in chemistry, Master’s in Biochemistry and Ph.D. in Biotechnology from Pune University and Bhabha Atomic Research Centre (BARC). She is a gold medallist from Pune University for Master’s in Biochemistry. She has 5 publications to her credit in the areas of Proteomics and downstream protein purification.She likes reading and is passionate about learning recent advances in Biotechnology.
SHAHU INGOLE
Wockhardt
SHAHU INGOLE
Wockhardt
SHAHU INGOLE, General Manager, Head Medical Affairs, Wockhardt
Dr Shahu was working as General Manager and Head Medical Affairs, Wockhardt Ltd. Mumbai. Currently he is CEO of Science Plus. He has more than 20 years of experience in Medical Affairs, Clinical Research, Clinical Practice and Academics.
He has rich experience in various therapeutic areas including Diabetes, Metabolics, Cardiology, Nephrology, Orthopaedics, Gynecology and worked as Head of Institution Business and Clinical Research.
He has expertise in planning and execution of various Medico-marketing activities with innovative Medical Strategies, New Product Evaluation and launch, scientific support to external and internal stakeholders, and proficiency in managing a team of Medical Advisors, Medical Reviewers, Clinical Research Associates.
He has done more than 15 Scientific Poster Presentations in National & International Conferences, 41 Publication in indexed National & International Journals.
MOHIT AGARWAL
Sun Pharma
DEEPA ARORA
CLINEXEL Life Sciences
DEEPA ARORA
CLINEXEL Life Sciences
DEEPA ARORA, Chief Executive Officer, CLINEXEL Life Sciences
Deepa is an Experienced Clinical Development and Drug Safety physician. She served in leadership positions in pharma companies for almost two decades, leading global clinical research and pharmacovigilance activities. Currently she is the Chief Executive Officer of Clinexel Life Sciences Pvt Ltd.
CLINEXEL is an agile, customer focused full service, Clinical Research Organization, that provides clinical research, pharmacovigilance, regulatory, auditing and medical writing services to pharma, biotech and medical device companies. At CLINEXEL, our mission is to partner with early-stage pharma and biotech companies for fast and efficient clinical development of their innovations.
MILIND ANTANI
Nishith Desai Associates
MILIND ANTANI
Nishith Desai Associates
MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates
• Dr. Milind Antani is a Leader of the Pharma & Healthcare Practice a at the multi-skilled, research-based international law firm, Nishith Desai Associates with offices in Mumbai- Nariman Point, Silicon Valley, Bangalore, Singapore, New Delhi and Mumbai – BKC, Munich and New York. He is also partner in-charge of Social Sector practice and Nanotechnology practice.
• Dr. Antani represents clients on strategy matters including corporate mergers and acquisitions, investments, regulatory and transactional matters, intellectual property prosecution and litigation, collaborations including joint ventures and formation of new companies. He also advises clients in e-Health and tele-medicine on business strategy from legal and regulatory perspective.
• He has authored and co-authored many articles, publications related to the pharma and healthcare industry including a book on CRAMS, and Pharma and Life science. The have also contributed a chapter on India in ‘Commercialization of Healthcare-2nd Edition Global Guide’ published by Thompson Reuters in 2015. He is a regular speaker and panelist at various national and international forums on the subjects of pharma, biotech, IP, clinical trials, healthcare, CSR, FCRA. He is also a visiting faculty at many institutions in Mumbai.
• He has been included as one of the world's leading practitioners in ‘Who's Who Legal’ for Life Sciences 2014 and 2015 in the ‘Regulatory’ section as only lawyer from India.
• Dr. Antani practiced as an ENT surgeon for 14 years prior to joining Nishith Desai Associates as a lawyer.
• He has also successfully attended "Managing and Transforming Professional Service Firms-India” an executive training program organized by HARVARD BUSINESS SCHOOL.
RAJKUMAR M
Abbott
AKSHAYA ODAK
Lupin
AKSHAYA ODAK
Lupin
AKSHAYA ODAK, Head - Regulatory (Biotech), Lupin
• Akshaya S. Odak is currently Head – Regulatory ‐Biotechnology Division of Lupin limited based in Pune, Maharashtra.
• Prior to that, he was looking after the regulatory function for the registration of Biotechnology products of Wockhardt Limited, Aurangabad.
• During regulatory tenure, worked primarily on biosimilars and has a vast experience of regulatory dossier filing and product approval in US, EU, Japan, India and more than 70 countries.
• He has also faced regulatory audits from different agencies viz., US FDA, EU, PMDA, ANVISA, GCC and other countries.
• He has an industrial experience of around 29 years and has also worked for companies like Hoechst India Ltd., and Ranbaxy Laboratories Ltd. His prior experience included development and production of Biologics.
• He has done his Master’s, M.Phil., and Ph.D. from Jiwaji university, Gwalior.
SANTOSH J
Bharat Serums and Vaccines
SANTOSH J
Bharat Serums and Vaccines
SANTOSH JADHAV, Deputy General Manager - Quality Control, Bharat Serums and Vaccines
Santosh Jadhav serves as DGM, Biotech Quality Control at BSV, where he is the principal authority on allmatters related to handling of QMS, Audits and commercial testing and release of biological products to the market. In his current role he provides regulatory guidance, manages,and leads teams in strategic decision making, ensuring quality submissions to the Food and Drug Administration.
Santosh jadhav earned his master’s degrees in biotechnology from the University of Nanded (SRTMU) and his bachelor’s degree in Microbiology from DSM college, Parbhani. He spent 18 years in pharmaceutical industry at Wockhardt, Panacea Biotec, Intas, Lupin and Stelis Biopharma.
An accomplished analytical researcher and QC operations leader with expertise in the areas of analytical method development and validations, strategic planning & execution, Regulatory Compliance, policy development & risk mitigation, quality data collection & analysis and drug product research & development.
He has a broad spectrum of scientific andmanagement experience from industry.Prior to joining BSV, he worked at Stelis Biopharmaceutical (CDMO) as Quality control Head and contributed to file 4 ANDA to the US FDA and 1 MAA application to EMEA. He served as Key team member for development of first Indian filgrastim Biosimilar product (Intas Grastofil®) approved by European Regulatory agency. He also, significantly contributed towards development of etanercept biosimilar (Nepexto®-Lupin) and filgrastim Biosimilar (Lupifil®) which was later approved by EMEA and PMDA respectively.The main areas of hisinterestare Chromatographic (HPLC, UPLC) and Capillary Electrophoresis (CE) based method development and validations for Biologics, especially for the monoclonal Antibodies, Statistical Data analysis (DoE, R&R gauge, ANOVA, Control Charts etc.), Technology transfer, Quality Management System (Change control, Deviation, CAPA, OOS, OOT etc.), Process validation, Aseptic processing practices, cleaning validation in line with PDA TR29 and TR49, Device testing as per ISO 11608 and USP <380>, Interpretation of FDA warning lettersto find gaps in the quality systems.
Through his 18-year professional career, he has established his leadership in industrial R&D, quantitative methods and modeling, and model based strategic decision makings in regulatory and industrial settings for generic and new drugs.
PANKAJ THAKUR
Hetero Labs
PANKAJ THAKUR
Hetero Labs
PANKAJ THAKUR, GM, Clinical Project Management - Drug Discovery, Biologics, Hetero Labs
SHALU KASLIWAL
Dr. Reddy’s Laboratories
SHALU KASLIWAL
Dr. Reddy’s Laboratories
SHALU KASLIWAL, Group Lead- Medical Sciences, Biologics, Dr. Reddy’s Laboratories
Dr.Shalu Kasliwal, associated with pharma industry approximately 15 years, currently associated withDr Reddy’s Biologics division since last 5 years as Group Lead-Medical Operations and responsible for medical challenges during the studies conducted here.
Before this, she was associated with multiple CROs where she got rich experience on Pharmacovigilance activities as safety physician for various NBE/NCEs as well as established molecules, PK studies on small molecules, transdermal patches and various dermal preparation.
SWEETY MATHEW
Novo Nordisk
SWEETY MATHEW
Novo Nordisk
SWEETY MATHEW, Regulatory Professional- Global Regulatory Affairs: CMC Rare Diseases, Novo Nordisk
• Sweety Mathew is part of Global Regulatory Affairs- CMC Rare Diseases team in Novo Nordisk and was earlier associated with Biocon Biologics handling peptides and biosimilars.
• Prior to being a Regulatory professional, she was associated with BioMarin Pharma- UK (Rare Diseases) and part of RnD team as a Cell and Molecular Biologist.
• She is a post graduate in Bioinformatics and Applied Biotechnology from University of Westminster, London.
• She believes in nurturing an inquisitive and an explorative culture to be part of this exciting race to create a more scientifically advanced tomorrow.
APARNA P
Wockhardt
APARNA P
Wockhardt
APARNA PRABHUNE, Asst General Manager Regulatory Affairs, Wockhardt
Regulatory Affairs Expert with 18 years’ experience in handling regulatory activities for ROW markets, including Asia, Africa, CIS and America.
Have worked with companies like Cipla, Khandelwal Labs Pvt Ltd and Merck Ltd. At present working as AGM- Regulatory Affairs with Wockhardt Ltd.
Responsible for handling all in all Regulatory activities for India business for NCEs, ND, SNDs, Medical devices, Cosmetics and Food Supplements.. Also have expertise in Pharmacovigilance, Strategy planning for new product launches.
VISHWAS SOVANI
Pharmawisdom
VISHWAS SOVANI
Pharmawisdom
VISHWAS SOVANI, Founder Director, Pharmawisdom
• Founder Director, Pharmawisdom, a consultancy that focuses on clinical research, training and pharmacovigilance coaching.
Qualification:
• MD (Pharmacology), Mumbai University.
• Diploma in Management, IIM Ahmedabad.
• Over 35 yrs in pharma industry in medical department,
• Responsible for Clinical research, regulatory & medicomarketing and pharmacovigilance in companies like Sarabhai, Cipla, FDC, Cyanamid/Wyeth, Organon, in local and regional roles
• Was also Head of Pharma delivery in TCS BPO
• Retired as India Head for Revogenex Inc.
Additional professional activities:
• Chairman of the Ethics Committee of the Kaushalya Medical Trust Hospital.
• Medical expert in Ethics Committee for Jaslok Hospital.
• Ex-Chairman of Institutional Review Board of Bombay College of Pharmacy, Mumbai.
• Ex Referee and examiner for M. Pharm. (Pharmacology) & Ph. D (Pharmacology) course of University of Mumbai.
Publications:
BOOKS: Updates in Ophthalmology as editor.
JOURNALS: Over 45 publications in various therapeutic areas.
PRASHANT B
CliniSearch
PRASHANT B
CliniSearch
PRASHANT BODHE, Director, CliniSearch
Profile Description:
Pharmacologist with 24+ years of experience in Regulatory Affairs; Quality Compliance and Systems; Global Clinical Research (Phase I-III) & Pharmacovigilance; API, Toxicology; Formulation Development; Bioavailability, Bioequivalence Studies, Pharmacokinetics
Professional Experience
Director
CliniSearch; Proprietor; Consultant, Pharmaceutical Research and Development
June 2014 - Present
Director of Operations, Medanta Duke Research Institute (MDRI)
Medanta The Medicity Sector 38, Gurgaon, Haryana, 122001, India; Aug 2013 – June 2014
Associate Director, Clinical Operations & Office Head, Sri Lanka Quintiles Research (India) Pvt. Ltd.; Feb 2011 – June 2012
Director, Clinical Development Center
Advance Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Center, Navi Mumbai; Jan 2008 - May 2010
Vice President
CliniSearch Biotechnologies, Navi Mumbai, India; Dec 2003 - Dec 2007
Deputy General Manager (Senior Clinical Pharmacologist) Lupin Research Park, Pune, India; Dec 2002 - Dec 2003
Head Regulatory Affairs (India Region) Cipla Ltd., Mumbai, India; Jul 2000 - Dec 2002
Assistant Manager, Department of Pharmacology, Toxicology, Research and Development
Cadila Pharmaceuticals Ltd., Ahmedabad, India; Since Dec. 1998 to Jul. 2000
Senior Research Fellow
Liposome Clinical Pharmacology Center, Dept. of Clinical Pharmacology, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, India; Nov. 1991 - Dec. 1998
Research Fellow
Indian Institute of Toxicology, Pune, India; Apr. 1988 - Oct. 1991
Professional Memberships
- Life member of ACTREC Alumni Association, Tata Memorial Center, Kharghar, India
- Indian Pharmaceutical Association (Life Member)
- Registered Pharmacist (Life)
Publications
- 13 scientific papers in indexed International (4) and National publications (9)
- Presentations: http://www.slideshare.net/PrashantBodhe
SAKHARAM G
Renovare Healthcare
SAKHARAM G
Renovare Healthcare
SAKHARAM GARALE, Founder & CEO, Renovare Healthcare Solutions
• Dr. Sakharam Garale, is Physician with E-MBA from IIM-Indore, BCMAS(USA), perusing a PhD in management with over 20 years of rich experience; in Global Medical Affairs, Medico-marketing, Clinical Research & Development, Public Health, Regulatory Affairs, Pharmacovigilance, Project Management, Vendor Management, Compliance, People Management in the Pharmaceutical & Healthcare industry.
• He has had exposure to domestics and international markets with MNCs like Mylan Laboratories Ltd, Abbott Ltd, Quintiles Translational Ltd, Sandoz India Ltd and Glenmark Pharmaceuticals Limited.
• He brings extensive experience of working in international markets i.e. Emerging Markets (LATAM, ASIA, Africa and JANZ) along with India for Global Medical Affairs, Medico-Marketing, Public Health, Commercial leadership, Operations and Strategy.
• He also has upper hand in setting up the units and managing Bioavailability & Bioequivalence studies with leading CROs, local and MNC Pharma organization in the industry at different levels.
• He is a well known KOL, Speaker and Trainer in Healthcare industry seen at various events and conferences in India and APAC.
• Associated with small and medium size healthcare/pharmaceutical startups as consultant for operations and strategy. With his vast international experience and exposure, he brings a detailed insights from international healthcare markets for commercial exchange.
• Founded Renovare Healthcare Solutions in 2018 with its office in Navi Mumbai to cater to KOLs, Hospitals and Pharmaceutical Industry serving global clientele.
• As part of CSR, Renovare has trained 7000+ people from different sections of society on covid-19 awareness during 1st wave and treated 5000+ covid-19 patients with a home care model during both covid-19 waves.
ROSHAN PAWAR
Alkem Laboratories
“Uniting industry leaders to analyze advanced commercial developments & to identify successful management strategies of Biosimilars”
Event Schedule
Meet and to network with your conference colleagues.
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues
CHALLENGES & OPPORTUNITIES
09:30 – Future of Biopharma industry
KETAKI SABNIS-PRASAD, Assistant Director & Head Development Quality Assurance Biotech, Lupin
10:00 – DISCUSSION WITH EXPERTS: Biosimilars 2022 Analyzing the potential challenges
• Biosimilars manufacturing – Expectations Vs reality
• Future of Interchangeability – What has to be done?
• Real world challenges in implementation of Biosimilars
• Clinical trials and Pharmacovigilance for biosimilars – What are recent developments?
• Reference product and the biosimilars – How to maintain the relationship?
• Biosimilars in rare diseases: An opportunity
Moderator
VISHWAS SOVANI, Founder Director, Pharmawisdom
Panellists
SHALIGRAM RANE. Vice President & Site Head Quality, Lupin
PANKAJ THAKUR, GM, Clinical Project Management - Drug Discovery, Biologics, Hetero Labs
SHAHU INGOLE, General Manager, Head Medical Affairs, Wockhardt
ROSHAN PAWAR, Associate General Manager, Alkem Laboratories
KAVYA KADAM, Consultant Global Clinical Trials
10:50 – Morning Coffee/Tea & Discussion
MARKET ACCESS & IMPLEMENTATION
11:10 - DISCUSSION WITH EXPERTS: Unique challenges to market access for Biosimilars
• What are the current market trends affecting the biosimilar?
• Addressing the challenges of market implementation in biosimilar especially under post-pandemic
• Entry strategies, countermeasures to economic impact & marketing channels
• Key factors that impacting market and economic growth
• New product and existing product strategies to maintaining sustainability in biosimilars
Moderator
PRASHANT BODHE, Director, CliniSearch
Panellists
RAJKUMAR MALAYANDI, Head Biopharmaceutics & Clinical Pharmacokinetics, Abbott
MOHIT AGARWAL, Head of Emerging Markets – SFE, Sun Pharma
VENKAT NATARAJAN, Heading Access Initiatives, Pfizer
SHALU KASLIWAL, Group Lead- Medical Sciences, Biologics, Dr. Reddy’s Laboratories
SEEMA BHANDARKAR, Global Program Manager Biosimilar Operations, Biocon
GAURAV AGARWAL, New Product Introduction Project Manager, Abbott
12:00 – Designing and Conducting Clinical Trials of Biosimilars - Building Operational & ScientificEfficiency
• Evolution of the Biosimilar Regulatory Framework - Past & Future
• Understanding Phase 3 Trial Designs
• Biosimilar to biosimilar switching- Rationale & current experience
• Streamlining regulatory approvals of biosimilars
DEEPA ARORA, Chief Executive Officer, CLINEXEL Life Sciences
12:30 – Networking luncheon
PRODUCT DEVELOPMENT
13:50 – DISCUSSION WITH EXPERTS: Future direction for product development in Biosimilars
• Analytics - How will it help to make things better?
• Upstream processing & Downstream processing – Risk and benefits
• Risk of adverse effects related to new drug development. How to overcome that?
• How to keep ensuring the balance between product development and patient safety?
• How to speed up the process of development and reduce costs of production?
• Product compatibility and regulatory aspects
Moderator
DEEPA ARORA, Chief Executive Officer, CLINEXEL Life Sciences
Panellists
MUKESH KUMAR,Senior Vice President & Head, Clinical R&D, Cipla
SUYAMBURAM SATHASIVAM, Associate Vice President, Sun Pharma(UAE)
GODHULI CHATTERJEE, Senior Medical Advisor, India – South East Asia Cluster, Sanofi
SAMIR KULKARNI, Head, Biological Sciences and Biotechnology, Institute of Chemical Technology
SAKHARAM GARALE, Founder & CEO, Renovare Healthcare Solutions
14:40 – Device and its component testing for drug device combination products
SANTOSH JADHAV, Deputy General Manager - Quality Control, Bharat Serums and Vaccines
15:10 – Afternoon Tea / Coffee
15:30– Overview of the Regulatory considerations for Novel and Biosimilar product development
• Overview of novel and biosimilar molecule development
• Current biosimilar landscape
• Overview of regulatory requirements & interchangeability
SWEETY MATHEW, Regulatory Professional- Global Regulatory Affairs: CMC Rare Diseases, Novo Nordisk
REGULATORY
16:00 - DISCUSSION WITH EXPERTS: Overview of regulatory guidelines for Biosimilars
• What are the recent developments in regulatory that impact the biosimilar industry?
• Regulatory requirements for approval of biosimilars
• Interchangeability and switching biosimilar: Regulatory’s view
• Clinical-phase-appropriate regulatory compliance in the development of biosimilars
• FDA and EU regulatory – What can be learnt from that side towards our market?
Moderator
MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates
Panellists
RAHUL GUPTA, Sr.Vice President, Regulatory Affairs, USV
DEEPA ARORA, Chief Executive Officer, CLINEXEL Life Sciences
HARSHAD KOTHAWADE, Director, Head of Regulatory Management & Trade Compliance India, South East Asia, ANZ, Merck KGaA
AKSHAYA ODAK, Head - Regulatory (Biotech), Lupin
APARNA PRABHUNE, Asst General Manager Regulatory Affairs, Wockhardt
16:50 – Chairperson closing remarks and end of the conference
Share
Now
Event Sponsors & Partners
CLINEXEL Life Sciences
CLINEXEL is a full service CRO. We provide science driven customized, cost- effectiveand time sensitive efficient early phase clinical development solutions. We are providing end to end clinical trial, regulatory, pharmacovigilance and medical writing services to pharma, biotech and medical device companies.
CLINEXEL Senior Management have strong experience in large pharma and biotech companies therefore, understand the business needs and challenges of clinical development, and key aspects of life cycle management of pharmaceuticals.
We are supporting small and mid-size pharma and conducting Phase 1, 2 and 3 Clinical Trials for NCEs and Biologicalsand Pharmacovigilance regulatory compliance activities.
Visit our website: www.clinexel.com
ClinChoice
“ClinChoice is a leading full-service clinical CRO offering high-quality solutions to pharmaceutical, biotechnology, medical device and consumer products clients. We contribute to a safer and better world by helping our sponsor clients accelerate drug and device approvals to market. We do this by combining our 25 years of proven quality and results with expertise in 30+ therapeutic areas, a flexible approach, and dedicated teams who enable rapid startups and fast timelines.
Our commitment to the highest quality standards, flexibility, and timeline fulfillment has earned us and our clients consistent results. We provide services for the full development lifecycle to a wide range of clients, large and small, including six of the top 10 pharmaceutical companies, as well as small to midsize biotechnology companies. For us, our record of quality means consistency, accuracy and reliability. For you, it means a reliable partner and quality results.”
Visit our website: www.clinchoice.com
Krishgen BioSystems
Krishgen is one of India's largest distributors for the life sciences industry, and a reputed manufacturer of immunoassays being used worldwide for biologics research and production. Est. 2003, we represent 70+ companies in India from around the world, being amongst the top 3 vendors to all the major biopharma, pharma and CROs.
Krishgen is a tech-focused company, and we work closely with our customers to ensure the latest, cutting-edge technologies and reagents are offered to them.
We currently also manufacture thelargest range of biosimilars ELISA, as well as some of the most uniquely specific biopharma assays in the world. Since 2008, we have been cited in 1200+ publications in journals around the world, in various research areas. With15+ distributors around the world, our products have been used in leading pharmaceutical and biotech companies in the US, Germany, Russia and China.
Our strength as a leading distributor and manufacturer lies in our expert technical team, prompt service, custom built ERP software and our core values of transparency and customer-first approaches.
From proteins, antibodies, biological compounds, cell lines and glycosylation tools to assays and toxicology / bioprocessing tools, Krishgen has it all. We are the one-stop shop for all research needs.
Visit our website: www.krishgen.com
Logical Life Science
We are a collaborative preclinical contract research organization, focusing on Cell biology, Cancer biology, and T-cell and B-cell immunobiology based out of Pune. We work with Universities, Biotech Firms, BioPharma companies, Pharma companies, and individual researchers. We provide research and testing services on immunology, T cell biology, anti-cancer drug screening, and mechanism analysis, and immunomodulatory drug screening and mechanism analysis. Our lab provides industry-leading technologies such as Multicolor flow cytometry and MACS (magnetic cell sorting), along with rapid and modern drug screening analyses that are biologically more relevant than other conventional techniques.
Aided with our connections to reputed hospitals for the provision of samples for in vitro testing and novel protocol development for ultra-modern and updated techniques for reshaping the future of biologics, biosimilars, biopharmaceuticals, and pharmaceuticals. We also provide consultancy services in the field of flow cytometry, cell culture, and cell sorting technologies. We have developed and optimized several protocols such as Mixed lymphocyte reaction (MLR), in vitro Tcell activation, immune cell sorting, monocyte-to-dendritic cell differentiation, testing of innate immunogenicity and adaptive immunogenicity as well as single-cell cloning of human T cells. These techniques/ protocols are crucial for drug screening and drug development as mandated by regulatory bodies around the globe. The pharmaceutical and biopharmaceutical industry could benefit from such services because they are accurate, rapid, and provide deeper insight into the efficiency of drugs and their mechanism at the cellular level.
We have optimized around 23 protocols, acquired 17 clients, and collaborated with more than 10 research projects. We have published 12 research articles in reputed journals in the last two years.
Contact: Sameer (for business queries) : +91 9920560510 / Dr. Nishant Vyas (for technical queries): +91 8698684792
Visit our website: www.logicallifescience.com
Virtue Insight
CONCEPTUALISED BY
Virtue Insight
CONCEPTUALISED BY
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
Testimonials
Jakob& Partners Senior Business Analyst
Regulatory Affairs Sanofi Senior Manager
LUPIN BIOTECH BUSINESS DEVELOPMENT & PM
JAKOB & PARTNERS INDIA PVT LTD BUSINESS ANALYST
Quantimmune Solutions Senior Research Scientist
Gangwal Chemicals GM - Technical Sales and Marketing (South region)
Intas Pharma Business Development
Biocon Biologics Manager – Compliance
Lupin BD Manager
Venue Details
Venue:
Hotel Kohinoor Continental
Address: Andheri Kurla Road, Andheri ( E ),
Mumbai – 400059
Maharashtra, India
Phone: 022 6769 3500
